Pfizer announces major share sale in Haleon plc alongside a strategic share buyback
LONDON, UK: Pfizer Inc. has declared its intention to offload a substantial portion of its shares in Haleon plc. The transaction involves approximately 630 million...
Saama and Pfizer expand AI partnership to accelerate clinical trials
Saama, a leading provider of AI-based solutions for clinical development and commercialization, announced a new multi-year agreement with Pfizer, a global biopharmaceutical company, to scale...
Pfizer and BioNTech propose expansion of pivotal Covid-19 vaccine trial
NEW YORK: BioNTech and Pfizer have submitted an amended protocol to the U.S. Food and Drug Administration to expand the enrollment of their Phase 3...
COVID-19: Pfizer and BioNTech commence pivotal Phase 2/3 global study
NEW YORK: Pfizer Inc. and BioNTech SE announced the start of a global (except for China) Phase 2/3 safety and efficacy clinical study to evaluate...